The Many Uses of Metformin. Is it a Wonder Drug?

Metformin was originally discovered in 1922 by a French physician by the name of Jean Sterne. Studies of the drug in humans began in the 1950’s. Metformin was introduced in France as a medication in 1957, then in the United States it was first approved by the FDA in 1995. Metformin is a drug that has been used for decades to treat type 2 diabetes. However, recent research has revealed that this medication may have a host of other uses as well.

One of the most exciting areas of research for metformin is its potential to extend lifespan and reduce the risk of age-related diseases. Studies in animal models have shown that metformin can improve health span and extend lifespan (1). This is a fascinating area of research as the medical community begins to seriously debate whether “aging” itself should be categorized as a disease.

Another area of research is metformin’s potential as a cancer-fighting agent. Studies have shown that metformin may reduce the risk of certain types of cancer, including breast cancer (2).

Metformin has also been studied for its potential in treating polycystic ovary syndrome (PCOS). PCOS is a common condition that affects women and is characterized by irregular periods, acne, and weight gain. Studies have shown that metformin may improve the symptoms of PCOS and improve fertility (3).

In addition to these approved uses, metformin is also being studied for its potential in treating a variety of other conditions including non-alcoholic fatty liver disease, obesity, and heart disease.

So is Metformin a potential wonder drug? What do you think? It’s important to note that while the research on metformin’s potential in treating these conditions is promising, further studies are needed to confirm its effectiveness and safety. Also, as with any medication, it’s important to consult with your healthcare provider before starting or stopping any treatment.

(1) Sinclair, D. A., et al. “Metformin as a Tool to Target Aging.” Cell Metabolism, vol. 30, no. 2, 2019, pp. 181–197., doi:10.1016/j.cmet.2018.11.006.

(2) Jenkins, D. J., et al. “Metformin: The Evidence Base for Its Role in Type 2 Diabetes.” Diabetes, Obesity and Metabolism, vol. 18, no. 2, 2016, pp. 146–162., doi:10.1111/dom.12629.

(3) Lord, J. M., et al. “Metformin in polycystic ovary syndrome: systematic review and meta-analysis.” BMJ, vol. 337, 2008, pp. a2354–a2354., doi:10.1136/bmj.a2354.

*This article was produced with the assistance of artificial intelligence. Please always check and confirm with your own sources, and always consult with your healthcare professional when seeking medical treatment.